Linyan Xu

760 total citations
44 papers, 516 citations indexed

About

Linyan Xu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Linyan Xu has authored 44 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Linyan Xu's work include Lymphoma Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Linyan Xu is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Linyan Xu collaborates with scholars based in China, United States and Australia. Linyan Xu's co-authors include Liu X, Ling Su, Jian‐Ping Lang, Zhi‐Gang Ren, Chunyu Liu, Kailin Xu, Shiyuan Liu, David James Young, Hui-Fang Wang and Wentao An and has published in prestigious journals such as Blood, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Linyan Xu

39 papers receiving 510 citations

Peers

Linyan Xu

ONCOL

IMMUN

Pavel B. Davidovich Russia

Ewa Gniazdowska Poland

Kexiang Yan China

Fei You United States

Chien‐An Chen Taiwan

Yi‐Ling Huang China

Jelena Milovanović Serbia

Xiaomin Lu China

Jennifer L. Allensworth United States

Mateusz Psurski Poland

Pavel B. Davidovich Russia

Linyan Xu

241 ×1.2

108 ×1.1

154 ×1.8

ONCOL

25 ×0.3

138 ×2.0

IMMUN

Citations per year, relative to Linyan Xu Linyan Xu (= 1×) peers Pavel B. Davidovich

Countries citing papers authored by Linyan Xu

Since Specialization

Citations

This map shows the geographic impact of Linyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linyan Xu more than expected).

Fields of papers citing papers by Linyan Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linyan Xu. The network helps show where Linyan Xu may publish in the future.

Co-authorship network of co-authors of Linyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Linyan Xu. A scholar is included among the top collaborators of Linyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linyan Xu. Linyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Linyan, et al.. (2025). Is bottom-of-the-pyramid orientation a new reason for product imitation in emerging markets?. International Business Review. 34(4). 102452–102452. 1 indexed citations

Wei, Lihui, et al.. (2025). Impact of relative estradiol changes during ovarian stimulation on blastocyst formation and live birth in assisted reproductive technology. Scientific Reports. 15(1). 15617–15617.

Xu, Linyan, et al.. (2023). A Combination of CPI-0610 and SAHA Induces Apoptosis through STAT3 and p38 Signalling Pathways in Diffuse Large B-cell Lymphoma Cells. Current Medicinal Chemistry. 32(8). 1589–1605. 3 indexed citations

Xu, Linyan, Meng Zhang, Tianyi Lu, et al.. (2023). Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma. Journal of Pharmacology and Experimental Therapeutics. 387(3). 288–298. 4 indexed citations

Wang, Xiangmin, Qing Zhang, Hongyuan Zhou, et al.. (2023). Thymosin β4 Exerts a Cytoprotective Function and Attenuates Liver Injury in Murine Hepatic Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(8). 492.e1–492.e10.

Chen, Yun, et al.. (2023). Associations among risk perception, health efficacy, and health behaviors for cardiovascular disease: an application of risk perception attitude framework. Frontiers in Cardiovascular Medicine. 10. 1201789–1201789. 8 indexed citations

Liu, Ping, Ruichao Niu, Jie Chen, et al.. (2021). Epidemiological and clinical features in patients with coronavirus disease 2019 outside of Wuhan, China: Special focus in asymptomatic patients. PLoS neglected tropical diseases. 15(3). e0009248–e0009248. 14 indexed citations

Xu, Jiawen, Rong Wang, Ting Pan, et al.. (2021). CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia. Journal of Molecular Medicine. 99(10). 1447–1458. 5 indexed citations

Sang, Wei, Yuanyuan Qin, Ziyuan Shen, et al.. (2021). Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era. International Journal of Hematology. 114(2). 189–198. 6 indexed citations

10.

Jiang, Lingling, Linlin Nie, Lingling Yin, et al.. (2021). Prognostic Analysis of Patients with Primary Extranodal Lymphoma: A Retrospective Study. Cancer Management and Research. Volume 13. 2171–2180. 2 indexed citations

11.

Xu, Linyan, Xiang Gao, Yang Pu, et al.. (2020). EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells. Journal of Cancer. 12(4). 1011–1022. 8 indexed citations

12.

Xu, Linyan, Jun Jiao, Ziyuan Shen, et al.. (2020). Cladribine Induces ATF4 Mediated Apoptosis and Synergizes with SAHA in Diffuse Large B-Cell Lymphoma Cells. International Journal of Medical Sciences. 17(10). 1375–1384. 11 indexed citations

13.

Niu, Mingshan, Rong Wang, Tingting Shao, et al.. (2019). MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia. Frontiers in Oncology. 9. 1058–1058. 3 indexed citations

14.

Yang, Chen, Tingting Shao, Huihui Zhang, et al.. (2018). MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. Journal of Translational Medicine. 16(1). 267–267. 16 indexed citations

15.

Sang, Wei, Cai Sun, Cong Zhang, et al.. (2016). MicroRNA-150 negatively regulates the function of CD4+ T cells through AKT3/Bim signaling pathway. Cellular Immunology. 306-307. 35–40. 29 indexed citations

16.

Fu, Chunling, Yanqing Gong, Zengtian Sun, et al.. (2016). Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level. Oncology Reports. 36(3). 1605–1611. 12 indexed citations

17.

Qiao, Jianlin, Yujin Huang, Yuan Xia, et al.. (2015). Busulfan and cyclosphamide induce liver inflammation through NLRP3 activation in mice after hematopoietic stem cell transplantation. Scientific Reports. 5(1). 17828–17828. 20 indexed citations

18.

Chen, Ruihua, et al.. (2014). Correlations between serum levels of 25-hydroxyvitamin D and carotid atherosclerosis in patients with type 2 diabetes in Shanghai. Annales d Endocrinologie. 75(4). 206–212. 10 indexed citations

19.

Xu, Linyan, Ling Su, & Liu X. (2012). PKCδ Regulates Death Receptor 5 Expression Induced by PS-341 through ATF4–ATF3/CHOP Axis in Human Lung Cancer Cells. Molecular Cancer Therapeutics. 11(10). 2174–2182. 44 indexed citations

20.

Chen, Ruihua, et al.. (2012). Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: A cross–section study. Annales d Endocrinologie. 73(3). 208–212. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact